- Report
- January 2024
- 307 Pages
Global
From €5271EUR$6,178USD£4,350GBP
- Report
- January 2024
- 370 Pages
Global
From €6642EUR$7,784USD£5,481GBP
- Report
- March 2023
- 254 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- January 2023
- 352 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- January 2023
- 248 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- December 2022
- 325 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- October 2022
- 213 Pages
Global
From €4787EUR$5,609USD£3,950GBP
- Report
- May 2024
- 275 Pages
Global
From €5271EUR$6,178USD£4,350GBP
- Report
- February 2024
- 202 Pages
Global
From €4416EUR$5,000USD£3,772GBP
- Report
- October 2022
- 194 Pages
Global
From €4416EUR$5,000USD£3,772GBP
- Report
- November 2020
- 217 Pages
Global
From €3533EUR$4,000USD£3,017GBP
- Report
- April 2020
- 182 Pages
Global
From €3533EUR$4,000USD£3,017GBP
- Report
- January 2022
- 141 Pages
Global
From €4238EUR$4,799USD£3,620GBP
- Report
- April 2024
- 620 Pages
Global
From €6182EUR$7,000USD£5,280GBP
- Report
- March 2024
- 70 Pages
Global
From €4416EUR$5,000USD£3,772GBP
- Report
- March 2024
- 140 Pages
Global
From €4416EUR$5,000USD£3,772GBP
- Report
- March 2024
- 55 Pages
Global
From €4416EUR$5,000USD£3,772GBP
- Report
- January 2024
- 35 Pages
Global
From €4411EUR$4,995USD£3,768GBP
- Report
- December 2023
- 220 Pages
Global
From €4416EUR$5,000USD£3,772GBP
- Report
- October 2023
- 71 Pages
Global
From €4416EUR$5,000USD£3,772GBP

The COVID 19 Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. The market is also focused on the development of treatments and vaccines to combat the virus.
The Diagnostics market is driven by the need for rapid and accurate testing, as well as the need for treatments and vaccines. This has led to an increase in investment in the sector, as well as the development of new technologies and products.
Companies in the COVID 19 Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more